On March 26, 2019, the global leading peptide supplier Creative Peptides announced to update its therapeutic peptides for researchers who are dedicated to finding a cure for many diseases in the pharmaceutical industry
Shirley, New York - On March 26, 2019, the global leading peptide supplier Creative Peptides announced to update its therapeutic peptides for researchers who are dedicated to finding a cure for many diseases in the pharmaceutical industry. Till now thousands of ready-for-use therapeutic peptides can be easily found in this company, encompassing three categories: APIs, Peptide Inhibitors, and Tumor Antigen Derived Peptides.
Peptide therapeutics have played a notable role in medical practice since the advent of insulin therapy in the 1920s. As conventional cancer treatments are losing their therapeutic uses due to drug resistance, lack of tumor selectivity and solubility, the past decade has seen an increasing need to develop new therapeutic agents. Therapeutic peptides hence become a focus of the research circle as a promising and a novel approach to treat many diseases including cancer.
“So far, more than 60 peptide drugs are approved in the United States as well as other major markets. And we are happy to see that peptides continue to enter clinical development at a steady pace,” says Dr. Robert Martinez, head of Creative Peptides’ synthesis businesses, in a recent interview. “Peptide drug discovery has diversified beyond its traditional focus on endogenous human peptides to include a broader range of structures that are identified from other natural sources or through medicinal chemistry efforts. Through techniques like peptide drug bioconjugation, the application of therapeutic peptides has been further broadened.”
In comparison with proteins or antibodies, therapeutic peptides have several advantages: they are easy to synthesize; they have a high target specificity and selectivity; most importantly, they have low toxicity. However, therapeutic peptides do have some significant drawbacks related to their stability and short half-life.
APIs
Peptides used as APIs are of vital importance in the pharmaceutical industry due to the fact that only the good management of API peptides synthesis can better serve the pharmaceutical industry as well as the human health. Currently the peptide APIs available at Creative Peptides are all manufactured under USP guidelines and relevant regulations.
Tumor Antigen Derived Peptides
Antigen-based antitumor immunotherapy has grown rapidly in recent years. Tumor antigen is an antigenic substance produced in tumor cells that triggers an immune response in the host. There are two main categories of tumor antigens based on their pattern of expression: tumor-specific antigens (TSA), which are present only on tumor cells; Tumor-associated antigens (TAA), which are present on both tumor cells and some normal cells.
To know more about the therapeutic peptides at Creative Peptides, please visit: https://www.creative-peptides.
About Creative Peptides
With over a dozen of years’ experience in peptide manufacturing and synthesis, Creative Peptides has now gained a fame in custom peptide synthesis, stapled peptide synthesis, GMP manufacturing, peptide drug discovery as well as supplying API peptides, cosmetic peptides, catalog peptides, cell penetrating peptides, etc.
